You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》陸道培醫療再申請來港上市 淡馬錫前海方舟參投
阿思達克 02-01 09:19
中國內地血液病醫療服務提供商陸道培醫療再向聯交所提交上市申請,由中信証券、招銀國際及麥格理擔任聯席保薦人。集團曾先後於2023年1月及7月提交上市申請,去年初時曾有傳陸道培醫療計劃來港上市集資約4億美元。 最新招股資料顯示,該集團提供全週期血液病醫療服務,包括綜合醫院服務及血液病特檢服務。集團目前正營運河北燕達陸道培醫院、北京陸道培醫院亦莊院區及北京陸道培醫院順義院區,並計劃於今年首季新開上海陸道培醫院。股東背景方面,陸道培醫療已引入淡馬錫、前海方舟、PagodaTree基金、Investcorp等投資者。 截至去年9月底止首三季該集團錄收入14.21億元人民幣,按年增長14.5%。期內虧損錄7,239.1萬元人民幣,較2022年同期的虧損4.91億元人民幣收窄。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account